Results 1 to 10 of about 280,167 (140)

Scale-up of the DMPA-SC in Nigeria: Why policy matters [PDF]

BMC Women's Health, 2022
Background Injectable contraceptives have contributed substantially to Nigeria's rise in modern family planning methods usage. They are one of the most commonly used and preferred means of contraception among women in the country.
Oluwaseun Akinyemi, Nicole Danfakha, Adewole Adefalu, Ebony Easley, Kayode Afolabi, Olajimi Latunji   +5 more
doaj   +9 more sources

DMPA-SC stock: Cross-site trends by facility type [PDF]

Contraception: X, 2022
Objectives: To measure trends in the supply of DMPA-SC in public and private health facilities and compare with other prominent modern methods. Study design: We used repeated cross-sectional data from service-delivery-point surveys in six settings ...
Sophia Magalona, Shannon N. Wood, Frederick Makumbi, Funmilola M. OlaOlorun, Elizabeth Omoluabi, Akilimali Z. Pierre, Georges Guiella, Jane Cover, Philip Anglewicz   +8 more
doaj   +6 more sources

Perspectives on DMPA-SC for self-injection among adolescents with unmet need for contraception in Malawi [PDF]

Frontiers in Global Women's Health, 2023
IntroductionMalawi has made progress in expanding access to modern contraceptive methods over the last decade, including the introduction of depot-medroxyprogesterone acetate subcutaneous (DMPA-SC) in 2018.
Gracious Ali, Chelsey Porter Erlank, Frehiwot Birhanu, Melinda Stanley, Jessie Chirwa, Fannie Kachale, Andrews Gunda   +6 more
doaj   +7 more sources

Health care provider and client experiences of counselling on depot medroxyprogesterone acetate subcutaneous (DMPA-SC) for self-injection in Malawi. [PDF]

PLOS Global Public Health, 2023
Since the introduction of subcutaneous depot medroxyprogesterone acetate (DMPA-SC) in 2018, Malawi has achieved national coverage of trained providers in the public sector and steady increases in uptake of DMPA-SC.
Chelsey Porter Erlank, Gracious Ali, Frehiwot Birhanu, Melinda Stanley, Jessie Salamba Chirwa, Fannie Kachale, Andrews Gunda   +6 more
doaj   +7 more sources

Characteristics associated with use of subcutaneous depot medroxyprogesterone acetate (DMPA-SC) in Burkina Faso, Democratic Republic of Congo, and Uganda [PDF]

Contraception: X, 2021
Objectives: To what extent is DMPA-SC reaching new users versus encouraging method switching among existing users? Though increasingly-popular, little is known about characteristics of women using DMPA-SC in SSA.
Philip Anglewicz, Elizabeth Larson, Pierre Akilimali, Georges Guiella, Patrick Kayembe, Simon P.S. Kibira, Fredrick Makumbi, Scott Radloff   +7 more
doaj   +6 more sources

Cost-effectiveness of self-injected DMPA-SC compared with health-worker-injected DMPA-IM in Senegal [PDF]

Contraception: X, 2019
Objectives: To evaluate the cost-effectiveness of self-injected subcutaneous depot medroxyprogesterone acetate (DMPA-SC) compared to health-worker-administered intramuscular DMPA (DMPA-IM) in Senegal and to assess how including practice or demonstration ...
Mercy Mvundura, Laura Di Giorgio, Chloe Morozoff, Jane Cover, Marguerite Ndour, Jennifer Kidwell Drake   +5 more
doaj   +6 more sources

Lessons from the scale-up of provider-administered and self-injection of DMPA-SC in Nigeria: a landscape assessment [PDF]

BMC Women's Health
Background Nigeria is the seventh-most populous country in the world. Its high fertility rate and unmet need for family planning contribute to the increasing population size.
Adewole A. Adefalu, Tolulope O. Afolaranmi, Ebony Fontenot, Rachel Simon, Miranda Buba, Victor Dafe, Funmilayo Olabode, Mary Ajayi, Olajimi Latunji, Joy M. Dogo   +9 more
doaj   +7 more sources

How do pro-social tendencies and provider biases affect service delivery? Evidence from the rollout of self-injection of DMPA-SC in Nigeria [PDF]

BMC Women's Health
Background Inconsistent provision of subcutaneous depot medroxyprogesterone acetate (DMPA-SC) for self-injection (SI) undermines efforts to improve women’s reproductive health agency and access to self-care.
Calvin Chiu, Aminat Tijani, Madeline Griffith, Emily Himes, Sneha Challa, Chioma Okoli, Shakede Dimowo, Ayobambo Jegede, Jenny X. Liu   +8 more
doaj   +5 more sources

Enhancing the Introduction and Scale Up of Self-Administered Injectable Contraception (DMPA-SC) in Health Systems (the EASIER Project): Protocol for Embedded Implementation Research [PDF]

JMIR Research Protocols, 2023
BackgroundThe introduction of self-administered injectable contraception presents an opportunity to address the unmet need for family planning.
Colin Baynes, Petrus S Steyn, Kenneth Sherr, James Kiarie   +3 more
doaj   +4 more sources

Factors associated with the acceptability of self-injection training by clients receiving DMPA-SC services from community pharmacies and patent and proprietary medicine vendors in Nigeria [PDF]

BMC Women's Health
Background The self-administration of the subcutaneous depot medroxyprogesterone acetate (DMPA-SC) has the potential to empower women and improve contraceptive use. Several studies have demonstrated the acceptability of the provider-administered DMPA-SC,
Toyin O. Akomolafe, Emeka Emmanuel Okafor, Sikiru Baruwa, Osimhen Ubuane, Michael Alagbile, Delafrida Ukaga, Ijeoma Nwankwo, Rodio Diallo   +7 more
doaj   +5 more sources